SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SkinMedica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3458
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SkinMedica Inc (SkinMedica), a subsidiary of Allergan Plc, is a skin care service provider. The company offers cleanse, correct, moisturize and hydrate, protect, brighten, targeted treatments and professional peels among others. It provides essential serum, rejuvenating hydrator, total defence and repair, skin brightening complex and recovery complex, among others. SkinMedica gels for the treatment of mild to moderate atopic dermatitis creams for the reduction in growth of unwanted facial hair in women. The company offers products for treatment of hyper pigmentation. It markets products through physicians’ offices and online. SkinMedica is headquartered in Carlsbad, California, the US.

SkinMedica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SkinMedica Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
Partnerships 15
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 15
Acquisition 16
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 16
SkinMedica Acquires Colorescience, Maker Of Skincare Products 18
SkinMedica Inc – Key Competitors 19
SkinMedica Inc – Key Employees 20
SkinMedica Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SkinMedica Inc, Pharmaceuticals & Healthcare, Key Facts 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Colorescience Raises USD15 Million in Series B Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 12
Colorescience Raises US$15 Million In Venture Financing 13
SkinMedica Raises US$16.8 Million In Venture Financing 14
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 15
Allergan Completes Acquisition Of SkinMedica, Skin Products Maker, For US$350 Million 16
SkinMedica Acquires Colorescience, Maker Of Skincare Products 18
SkinMedica Inc, Key Competitors 19
SkinMedica Inc, Key Employees 20
SkinMedica Inc, Subsidiaries 21

List of Figures
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SkinMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SkinMedica Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Grupo TMM, S.A.B. (TMMA):企業の財務・戦略的SWOT分析
    Grupo TMM, S.A.B. (TMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Daya Materials Bhd (DAYA):企業の財務・戦略的SWOT分析
    Summary Daya Materials Bhd (DMB) is a chemical company that offers polymer compound solutions. The company provides bulk chemicals, catalysts, additives, inert support materials and deodorizing agents. Its polymer compound products include semi conductive compounds, medium-voltage XLPE compounds, lo …
  • MasTec Inc (MTZ):企業の財務・戦略的SWOT分析
    MasTec Inc (MTZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野:企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Murata Manufacturing Co Ltd (6981)-医療機器分野:企業M&A・提携分析
    Summary Murata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that carries out design, manufacture, and supply of advanced electronic materials, components, and multi-functional, high-density modules. Murata commercializes both finished and semi-finished goods. Its …
  • BE Semiconductor Industries NV (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries NV (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • China National Pharmaceutical Group Corp-製薬・医療分野:企業M&A・提携分析
    Summary China National Pharmaceutical Group Corp (Sinopharm) is a provider of medical and healthcare services. Its core businesses include the distribution, retailing, research and manufacture of healthcare related products. Its product portfolio includes EPI vaccines; biopharmaceutical products; an …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務情報
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Gemphire Therapeutics Inc (GEMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead produ …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • Malaysian Pacific Industries Berhad (MPI):企業の財務・戦略的SWOT分析
    Malaysian Pacific Industries Berhad (MPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Stellar Resources Limited:企業の戦略・SWOT・財務情報
    Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • Saudi Airlines Catering:企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務分析
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Industrial Alliance Insurance and Financial Services Inc.:企業の戦略・SWOT・財務情報
    Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the co …
  • Coca-Cola Amatil Limited:戦略・SWOT・企業財務分析
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fluor Corporation (FLR)-エネルギー分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • The Dow Chemical Co-エネルギー分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow), a subsidiary of DowDupont is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of custo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆